Slider with alias storia-EN not found.There is nothing to show here!
More than 35 years in diagnostic innovation solutions
Our inception came about in Padua, in 1988, as a result of our innovation-focused vision, and it is thanks to this foundational principle that we now embody innovation itself.
Intuition, entrepreneurship and innovation: the values that led Dr Paolo Galiano to utilise his decades-long experience in laboratory diagnostics to found Alifax, a revolutionary company, that is now one of the leading international players in the haematology, microbiology and molecular biology.
Our history and successes
Alifax has always focused on new products and innovation, thanks to continuous stimuli which are essential for this sector
TEST1 is one of our first great successes: back in the 90s, it completely revolutionised the way in which the erythrocyte sedimentation rate was analysed, by retrieving reliable results in just 20 seconds, thanks to quantitative capillary photometry
This patented technology can now be found in over 15,000 installations worldwide and has resulted in a considerable expansion – even on the foreign markets – by means of the industry’s largest multinational companies
OVER 35 YEARS OF SUCCESS
We owe all that we have become today to many factors: perseverance, commitment, research, the ability to question ourselves and a constant relationship-focused attention
1988
Foundation
1992
Uro-quick market launch
1997
TEST1 market launch
1998
Sire Analytical
Systems acquisition
1998
First international publication on Test1 technology (Plebani, Am J Clin Pathol)
2003
First ESR international congress in Busan, South Korea
2004
Roller 20 market launch
2004
European partnership with Beckman Coulter
2005
Alfred60 and ESR quality Controls market launch
2006
Opening of the new facilities in Polverara, Padova
2007
First publication about ESR Latex controls (Piva, Clin Biochem)
2009
First publication about Human Biological Liquid culture (Fontana, Med Sci Monit)
2009
Publication on Test 1 ESR results in patients suffering from different diseases (Cha, Am J Clin Pathol)
2010
PenOK sample collection
devices market launch
2012
US market introduction
2012
Opening of the new R&D
and production site in Nimis,
Udine
2013
Sidecar market launch
2015
2015 Opening of 3 subsidiaries in Moscow, Shanghai, Barcelona
2017
Inauguration of the new building in Polverara
2017
Opening of the new
Alifax R&D in Area Science Park, Trieste
2018
Opening the subsidiary
Alifax Brazil
2018
30th anniversary celebration
2019
New Logo
2020
Opening of the new subsidiary in Germany
2021
I-dOne market launch
2022
Molecular Mouse market launch
2022
NEW TEST1 2.0
market launch
Fortunate, indeed, to have crossed paths with great souls,
crafting a tapestry of wisdom and insight.
Intellectual honesty defines the scientists I’ve known,
individuals not just capable of teaching, but also adept at listening.
My belief is to exist, and in the industrial world,
Pursuant to the Ministry’s Guidelines on Health advertising for medical devices and in vitro diagnostic medical devices, the user is advised that the information contained on this website and which is being viewed is intended addressed solely to professional users and has not advertising purpose.